Table 2.
Monogenic vs. non-monogenica | Monogenic excluding GCK vs. non-monogenic | GCK only vs. non-monogenic | ||||
---|---|---|---|---|---|---|
N: monogenic vs. non-monogenic | 194 vs. 926 | 113 vs.926 | 81 vs. 926 | |||
Variable | P | OR [95% CI] | P | OR [95% CI] | P | OR [95% CI] |
Sex: female vs. male | 0.2866 | 1.22 [0.84–1.77] | 0.2139 | 1.32 [0.85–2.05] | 0.6597 | 1.13 [0.65–1.98] |
EuroCaucasian origin: yes vs. no | < 10−4 | 3.83 [2.48–5.95] | < 10−4 | 2.70 [1.66–4.41] | < 10−4 | 9.17 [3.57–23.26] |
N affected generations ≥ 3: yes vs. no | 0.0136 | 1.57 [1.10–2.25] | 0.0036 | 1.91 [1.24–2.96] | 0.798 | 1.07 [0.63–1.81] |
Age at diabetes | < 10−4 | 1.09 [1.07–1.11] | < 10−4 | 1.09 [1.06–1.11] | < 10−4 | 1.10 [1.06–1.13] |
BMI at diabetes | < 10−4 | 1.13 [1.08–1.17] | 0.0001 | 1.09 [1.04–1.14] | < 10−4 | 1.19 [1.11–1.27] |
Symptoms of diabetes: yes vs. no | < 10−4 | 0.30 [0.19–0.47] | 0.0036 | 0.48 [0.29–0.78] | < 10−4 | 0.06 [0.02–0.19] |
AUC of the ROC analysis | 0.82 | 0.79 | 0.89 |
aNon-monogenic, no genetic etiology detected by targeted NGS on 7 genes
BMI body mass index